Personalised Program for Women Treated for Hodgkin Disease : Risk Evaluation of Breast Cancer and Intensive Screening Program for Women at High Risk of Breast Cancer. PROPER/IPC 2010-001
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
efficacy of the screening
The efficacy of the screening will be evaluated by the rate of early stage breast cancer detected. The rate of in situ, < 10 mm(T1b), and N0 will be estimated.
15 years
No
François EISINGER, PhD
Principal Investigator
Institut Paoli-Calmettes
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
PROPER/IPC 2010-001
NCT01188915
July 2010
Name | Location |
---|